Phase 1 study (NCT04931823) of CPO100 (albumin bound docetaxel) in patients with advanced solid tumors
Shepard, Dale Randall, Kingsley, Ed, Powderly, John D., LoRusso, Patricia, Appleman, Leonard Joseph, Spira, Alexander I., Rosen, Lee S., Grebenc, Jessica, Ramirez, Ana Arlene, Noldin, Sydney, White, Hannah, Sarker, Erina, Behr, Sarah, Griengo, Janice, Lim, Christopher, Arvay, Lisa, Li, Yejia, Novick, Steven C., Obara, Grzegorz
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Outcomes of advanced urothelial carcinoma following discontinuation of programmed death (PD)-1 or PD-ligand (L)-1 inhibitors
Sonpavde, Guru, Pond, Gregory Russell, Mullane, Stephanie A., Ramirez, Ana Arlene, Vogelzang, Nicholas J., Necchi, Andrea, Powles, Thomas, Bellmunt, Joaquim
Published in Journal of clinical oncology (10.01.2016)
Published in Journal of clinical oncology (10.01.2016)
Get full text
Journal Article